476 related articles for article (PubMed ID: 8239865)
21. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
Chen MF; Suzuki H; Yano S
Anticancer Res; 1992; 12(2):451-6. PubMed ID: 1580562
[TBL] [Abstract][Full Text] [Related]
22. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
23. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
24. Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors.
Stein M; Gordon S
Eur J Immunol; 1991 Feb; 21(2):431-7. PubMed ID: 1999225
[TBL] [Abstract][Full Text] [Related]
25. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
26. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
27. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
28. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
29. [Antitumor efficacy of activated macrophages against murine glioma cells].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
[TBL] [Abstract][Full Text] [Related]
30. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
[TBL] [Abstract][Full Text] [Related]
31. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
[TBL] [Abstract][Full Text] [Related]
32. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Jun CD; Yoon HJ; Kim HM; Chung HT
Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
[TBL] [Abstract][Full Text] [Related]
33. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
Nelson BJ; Ralph P; Green SJ; Nacy CA
J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
[TBL] [Abstract][Full Text] [Related]
34. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
James SL; Skamene E; Meltzer MS
J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
[TBL] [Abstract][Full Text] [Related]
35. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
Belosevic M; Davis CE; Meltzer MS; Nacy CA
J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
[TBL] [Abstract][Full Text] [Related]
36. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
37. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.
Kirikae T; Ojima I; Ma Z; Kirikae F; Hirai Y; Nakano M
Biochem Biophys Res Commun; 1998 Apr; 245(3):698-704. PubMed ID: 9588177
[TBL] [Abstract][Full Text] [Related]
38. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
Remels L; Fransen L; Huygen K; De Baetselier P
J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
[TBL] [Abstract][Full Text] [Related]
39. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
40. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
